Assessment of Microbiome Variation During the Perioperative Period in Liver Transplant Patients: A Retrospective Analysis

Microbial Ecology

Volumn 65, Issue 3, 2013, Pages 781-791

  Lu, Haifeng ^a   He, Jianqing ^a   Wu, Zhongwen ^a   Xu, Wei ^a   Zhang, Hua ^a   Ye, Ping ^a   Yang, Jiezuan ^a   Zhen, Shusen ^b   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); BACTEROIDES; BIFIDOBACTERIUM; BIFIDOBACTERIUM DENTIUM; FIRMICUTES; HEPATITIS B VIRUS;

EID: 84876144358     PISSN: 00953628     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00248-013-0211-6     Document Type: Article

References (44)

1. (2004) Immunosuppressive drug interactions with anti-infective agents. Am J Transplant 4 Suppl 10: 164-166.
2. Arnow PM (1991) Infections following orthotopic liver transplantation. HPB Surg 3: 221-232, discussion 232-223.
3. Bartosch S, Fite A, Macfarlane GT, McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70: 3575-3581.
4. Beighton D, Gilbert SC, Clark D, Mantzourani M, Al-Haboubi M, Ali F, Ransome E, Hodson N, Fenlon M, Zoitopoulos L, Gallagher J (2008) Isolation and identification of bifidobacteriaceae from human saliva. Appl Environ Microbiol 74: 6457-6460.
5. Berdaguer S, Bautista J, Brunet M, Cisneros JM (2012) Antimicrobial and immunosuppressive drug interactions in solid organ transplant recipients. Enferm Infecc Microbiol Clin 30(Suppl 2): 86-92.
6. Binder M, Otto F, Mertelsmann R, Veelken H, Trepel M (2006) The epitope recognized by rituximab. Blood 108: 1975-1978.
7. Cakir M, Arikan C, Akman SA, Baran M, Saz EU, Yagci RV, Zeytunlu M, Kilic M, Aydogdu S (2010) Infectious complications in pediatric liver transplantation candidates. Pediatr Transplant 14: 82-86.
8. Chen Y, Yang F, Lu H, Wang B, Lei D, Wang Y, Zhu B, Li L (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54: 562-572.
9. del Pozo JL (2008) Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol 14: 4977-4983.
10. Duineveld BM, Rosado AS, van Elsas JD, van Veen JA (1998) Analysis of the dynamics of bacterial communities in the rhizosphere of the chrysanthemum via denaturing gradient gel electrophoresis and substrate utilization patterns. Appl Environ Microbiol 64: 4950-4957.
11. Ferris MJ, Muyzer G, Ward DM (1996) Denaturing gradient gel electrophoresis profiles of 16S rRNA-defined populations inhabiting a hot spring microbial mat community. Appl Environ Microbiol 62: 340-346.
12. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN, Glimcher LH (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131: 33-45.
13. Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, Bushman FD, Artis D (2010) Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3: 148-158.
14. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S (2011) Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60: 631-637.
15. Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB (2005) Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun 73: 6952-6961.
16. Lorian V (1994) Colonization resistance. Antimicrob Agents Chemother 38: 1693.
17. Lu H, Wu Z, Xu W, Yang J, Chen Y, Li L (2011) Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol 61: 693-703.
18. Lumbreras C, Lizasoain M, Moreno E, Aguado JM, Gomez R, Garcia I, Gonzalez I, Loinaz C, Cisneros C, Noriega AR (1992) Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology 39: 362-365.
19. Lupo L, Panzera P, Tandoi F, Carbotta G, Giannelli G, Santantonio T, Rendina M, Gentile A, Memeo V (2008) Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation 86: 925-931.
20. Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M (2005) Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43: 213-222.
21. Maukonen J, Matto J, Satokari R, Soderlund H, Mattila-Sandholm T, Saarela M (2006) PCR DGGE and RT-PCR DGGE show diversity and short-term temporal stability in the Clostridium coccoides-Eubacterium rectale group in the human intestinal microbiota. FEMS Microbiol Ecol 58: 517-528.
22. Mignat C (1997) Clinically significant drug interactions with new immunosuppressive agents. Drug Saf 16: 267-278.
23. Muller AK, Westergaard K, Christensen S, Sorensen SJ (2002) The diversity and function of soil microbial communities exposed to different disturbances. Microb Ecol 44: 49-58.
24. Muyzer G, de Waal EC, Uitterlinden AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59: 695-700.
25. Nakano V, Nascimento e Silva A, Merino VR, Wexler HM, Avila-Campos MJ (2011) Antimicrobial resistance and prevalence of resistance genes in intestinal Bacteroidales strains. Clinics (Sao Paulo) 66: 543-547.
26. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C (2011) Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5: 71-86.
27. Rollinghoff M, Schrader J, Wagner H (1973) Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro. Clin Exp Immunol 15: 261-269.
28. Salyers AAGA, Wang Y (2004) Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12: 412-416.
29. Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48: 322-335.
30. Simpson JM, Martineau B, Jones WE, Ballam JM, Mackie RI (2002) Characterization of fecal bacterial populations in canines: effects of age, breed and dietary fiber. Microb Ecol 44: 186-197.
31. Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG (1998) Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 13: 160-164.
32. Son G, Kremer M, Hines IN (2010) Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010: 453-563.
33. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
34. Thompson JR, Marcelino LA, Polz MF (2002) Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'. Nucleic Acids Res 30: 2083-2088.
35. Vanhoutte T, Huys G, Brandt E, Swings J (2004) Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 48: 437-446.
36. Vanhoutte T, Huys G, De Brandt E, Fahey GC Jr, Swings J (2005) Molecular monitoring and characterization of the faecal microbiota of healthy dogs during fructan supplementation. FEMS Microbiol Lett 249: 65-71.
37. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328: 228-231.
38. Wallemacq PE, Reding R (1993) FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 39: 2219-2228.
39. Wiesner RH, Hermans PE, Rakela J, Washington JA 2nd, Perkins JD, DiCecco S, Krom R (1988) Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 45: 570-574.
40. Wu ZW, Ling ZX, Lu HF, Zuo J, Sheng JF, Zheng SS, Li LJ (2012) Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int 11: 40-50.
41. Xie YR, Liu SL, Liu X, Luo ZB, Zhu B, Li ZF, Li LJ, He Y, Jiang L, Li H, Ruan B (2011) Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation. Transplant Proc 43: 3973-3979.
42. Xing HC, Li LJ, Xu KJ, Shen T, Chen YB, Sheng JF, Yu YS, Chen YG (2005) Intestinal microflora in rats with ischemia/reperfusion liver injury. J Zhejiang Univ Sci B 6: 14-21.
43. Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, Xu J, Li L (2012) Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microb Ecol 63: 304-313.
44. Zoetendal EG, Akkermans AD, De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64: 3854-3859.